Noah AA, El-Mezayen NS, El-Ganainy SO, Darwish IE, et al. Reversal of fibrosis and portal hypertension by Empagliflozin treatment of CCl(4)-induced liver fibrosis: Emphasis on gal-1/NRP-1/TGF-beta and gal-1/NRP-1/VEGFR2 pathways. Eur J Pharmacol 2023 Sep 26:176066. doi: 10.1016/j.ejphar.2023.176066.
PMID: 37769984